Back to the news portal
Health & Life SciencesResearch paperSource analysis

Neonatologists want AI as a second set of eyes—not the final word

Seventeen clinicians at one Dutch academic hospital welcomed AI for monitoring fragile newborns, but tied trust to local validation, human override and skills that must survive automation. The interviews reveal conditions for adoption, not evidence that an AI tool improved care.

By The Impact of AI Editorial DeskReleased 17 October 2026 at 06:27 BST2 min brief · full report optional1 source · view evidence
Share
Social links
LinkedInXBlueskyRedditEmail

The short version

  • 1.The study interviewed 17 neonatologists and trainees at one Dutch academic centre where two neonatal AI systems were being piloted.
  • 2.Clinicians described useful AI as an alarm or monitoring aid whose output remains subordinate to bedside assessment and can be overridden.
  • 3.This qualitative study measured professional views, not diagnostic accuracy, patient outcomes or actual reliance in a clinical trial.

Trust was conditional on keeping the clinician in control

The clearest finding is not that neonatologists trust AI. It is that they would consider relying on it only under conditions that preserve clinical control. Researchers interviewed 17 neonatologists and trainees at University Medical Center Utrecht, where teams had piloted one system for early detection of late-onset sepsis and another using electroencephalography to predict outcomes for extremely premature infants. Participants pictured AI as a continuous monitor or alarm: something that could filter more data than a person, flag a pattern and prompt a bedside assessment.[1]

Who it affects

For babies and families, the immediate issue is not whether an algorithm sounds trustworthy but whether it has been validated for similar patients, whether clinicians can challenge it and who remains accountable when signals conflict.[1]

Keep in mind

One primary source; 17 participants at one AI-experienced Dutch academic hospital; qualitative self-report; no diagnostic-accuracy comparator, patient outcomes or observed bedside decisions; final edited Version of Record is pending.

Source analysis · 1 linked source. Original source date: 17 October 2026.

Read more The full report, methods and context

Trust was conditional on keeping the clinician in control

The clearest finding is not that neonatologists trust AI. It is that they would consider relying on it only under conditions that preserve clinical control. Researchers interviewed 17 neonatologists and trainees at University Medical Center Utrecht, where teams had piloted one system for early detection of late-onset sepsis and another using electroencephalography to predict outcomes for extremely premature infants. Participants pictured AI as a continuous monitor or alarm: something that could filter more data than a person, flag a pattern and prompt a bedside assessment.

That role stopped short of automated authority. Clinicians wanted to know when they could follow or disregard a recommendation, retain the ability to intervene and compare an output with a baby's responsiveness, colour, family context and their own clinical judgement. Several worried that a validated alert could still create false reassurance or alarm fatigue. Others raised the opposite risk: legal or organisational pressure to follow an algorithm even when their assessment disagreed. The paper therefore maps acceptable reliance rather than a simple level of trust.[1]

The evidence came from detailed interviews, not a deployment trial

Twenty-six eligible clinicians were invited and 17 participated: nine women and eight men, with experience ranging from under one year to more than 21 years. Interviews lasted 29 to 59 minutes between November 2023 and May 2024, in person or online, and continued until the researchers judged that meaning saturation had been reached. The team analysed Dutch transcripts inductively in NVivo, checked two transcripts between coders and organised the results around trusting AI in practice, maintaining control and limits of trust.

This design can explain how clinicians reason, but it cannot tell us whether they would behave the same way under pressure or whether any system is safe. Everyone worked at the same specialised hospital and had at least some exposure to neonatal AI pilots. The researchers did not record each participant's level of AI expertise, and translating selected quotations from Dutch may have lost nuance. Parents, nurses and patients were outside the sample. The full transcripts are unavailable because they contain sensitive data.[1]

The distinction that matters

A clinician's proposed trust path

The interviews describe a sequence for justified reliance, not a tested safety protocol.

Validate

Test on the local patient population

Know where performance holds

Interpret

Combine the alert with bedside evidence

Check whether it fits this baby

Override

Keep a trained clinician able to intervene

Human responsibility remains

The paper measured clinicians' views. It did not compare this pathway with automated or unaided care. Source: BMC Pediatrics

For hospitals, validation must be local and continuing

Participants did not treat regulatory approval or a headline accuracy score as sufficient. They wanted evidence that a tool had been tested in a population resembling their own patients, clarity about which variables shaped validation, repeated performance in practice and training that would help them interpret probabilities such as a sepsis risk. They also wanted conventional clinical skills preserved for exceptions, outages and cases where an algorithm's data pattern conflicts with the whole patient.

The practical implication is that procurement should not end with buying a model. A hospital would need a local validation plan, explicit override rules, monitoring for alert fatigue and performance drift, education for every clinical role and a route for reviewing disagreements between system and clinician. Families also need a voice because decisions concern especially vulnerable patients. Confidence would rise through multicentre studies—including non-academic and lower-resource neonatal units—and prospective observation of decisions and patient outcomes. Until then, this single-centre study supports a design principle: AI may extend attention, but responsibility and contextual judgement stay human.[1]

Editorial illustration of healthcare professionals reviewing evidence.

The Royal Society

AI-generated illustration · not a video frame

YouTube loads only when you choose. Press play in the player to start. If playback is unavailable, use “Watch on YouTube” below.

Healthcare, culture & human impact · Background explainer

Published 2026-07-01 · 44 min 28 sec

Is this the AI future we want? | The Royal Society

A Royal Society discussion with Madhumita Murgia and biomedical engineer Alison Noble on AI’s potential in healthcare, science and culture, recorded at the 30 June 2026 event.

Evidence check: A discussion of opportunities and risks, including future possibilities. It is not evidence that every application described is available or clinically proven.

Source checked 14 October 2026. Check available captions on the publisher’s video page.

Evidence check

One primary source; 17 participants at one AI-experienced Dutch academic hospital; qualitative self-report; no diagnostic-accuracy comparator, patient outcomes or observed bedside decisions; final edited Version of Record is pending.

Reporting basis: Source analysis. Original source date: 17 October 2026.

Explore the full source and evidence record

What this means for people

  • For babies and families, the immediate issue is not whether an algorithm sounds trustworthy but whether it has been validated for similar patients, whether clinicians can challenge it and who remains accountable when signals conflict.

Global context

Neonatal units worldwide generate continuous monitoring data, but staffing, patient populations, devices, regulation and emergency capacity vary. Conditions described at a well-resourced Dutch centre cannot be assumed elsewhere.

What the evidence does not yet show

  • One primary source; 17 participants at one AI-experienced Dutch academic hospital; qualitative self-report; no diagnostic-accuracy comparator, patient outcomes or observed bedside decisions; final edited Version of Record is pending.

What to watch next

  • Prospective multicentre observation of clinician-AI disagreements, patient and parent perspectives, locally stratified validation, alert-fatigue measures, deskilling tests and explicit responsibility rules.

Living evidence record

Impact record IAI-06II6AW

Explore the full tracker

Evidence stage

Studied

Confidence

Supported

Reporting basis

Source analysis

Independent or research support

Present

Record status

Monitoring

Last checked

17 October 2026

Source trail

1 direct source across 1 source type.

People impact

Documented in this record.

Uncertainty

Limits and next checks are explicit.

Stages describe the evidence available—not whether a technology is good or bad. See the public method.

Single-source reporting disclosure

This record analyses one direct source. It can establish what BMC Pediatrics published or reported, but it is not independent corroboration of every performance claim or predicted outcome. The confidence label will change only when broader evidence is added.

Evidence trail

Sources used for this report

Links checked 17 October 2026

Research question, topics and regions

What neonatologists at an academic hospital believe would make reliance on AI reasonable in high-stakes newborn care

Topics: Neonatal care · Clinical AI · Trust · Human oversight · Medical validation

Regions: Netherlands · Europe · Global

This report is labelled source analysis. We summarise and analyse source material in our own words; company statements remain attributed claims until independently supported. Translated summaries preserve the meaning of the original source and link back to it. Read our editorial standards.

The Impact Brief · Free

Keep following the stories that matter to you.

Get our weekday briefing on what changed and why it matters. Choose your topics below.

Choose your topics (optional)

One concise, source-linked briefing. Unsubscribe at any time.

Continue the story

There’s more to this story

All reports

Health & Life Sciences

Can an adult X-ray AI learn neonatal care without moving patient data?

Across 30 neonatal intensive-care units, sequential local retraining cut average anatomical landmark error to 0.67 cm, compared with 1.29 cm for one-hospital fine-tuning and 4.30 cm for the unadapted adult model. The retrospective study did not deploy the system or measure harm, treatment changes or infant outcomes.

3 min · 3 sources

Health & Life Sciences

Is neonatal respiratory AI ready for routine care?

A peer-reviewed scoping review mapped 35 studies using AI and digital tools to predict, image or monitor newborn breathing problems. The evidence spans promising prototypes, but heterogeneity, small samples, limited external validation and few clinical-impact tests keep routine use unproven.

2 min · 2 sources

Health & Life Sciences

Did AI help radiologists read parotid ultrasound?

In a prospective reader study, three Korean radiologists improved pooled accuracy from 76.3% to 81.6% with an editable AI tool. But the system shifted errors between two tumour types, used only 107 surgical cases and has not shown better patient outcomes.

3 min · 1 source

Reader commentary

What does this mean where you are?

Tell us what you have seen at work, in your community or in everyday life. A question is welcome too. No account is needed; we review notes before publishing them.

Explore commentary across the portal →

Do not include personal, confidential or unlawful information.

Published reader notes

0

No published reader notes yet. You can start the evidence-led discussion above.

Prefer a private correction or response? Contact the newsroom.